Stockscreener 앱 받기
12.37
1.90%
-0.24
Abcellera Biologics Inc (ABCL) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
51.29%
4.05
|
8.315 | 44.85 | 8.955 | 17.08 |
Operating Expenses
|
1.51%
66.83
|
65.83 | 73.44 | 85.23 | 66.67 |
| Operating Income/Loss |
9.14%
-62.78
|
-57.52 | -28.58 | -76.28 | -49.59 |
| Nonoperating Income/Loss |
52.24%
3.812
|
7.982 | 9.083 | 7.51 | 13.24 |
| Income/Loss From Continuing Operations Before Tax |
19.03%
-58.97
|
-49.54 | -19.50 | -68.77 | -36.34 |
| Income Tax Expense/Benefit |
44.48%
-3.538
|
-6.372 | -10.55 | -11.65 | -1.617 |
|
Net Income/Loss
|
28.41%
-55.43
|
-43.16 | -8.945 | -57.12 | -34.73 |
| Basic Average Shares |
0.82%
305.56
|
303.07 | 0.3409 | 298.88 | 298.51 |
| Diluted Average Shares |
0.82%
305.56
|
303.07 | 0.3409 | 298.88 | 298.51 |
| Basic Earnings Per Share |
28.57%
-0.18
|
-0.14 | -0.03 | -0.19 | -0.12 |
| Diluted Earnings Per Share |
28.57%
-0.18
|
-0.14 | -0.03 | -0.19 | -0.12 |
2.04%
3.63%
자본화:
|
볼륨(24시간):